# TruVenturo

> TruVenturo is a VC fund in Hamburg backing Travel and Tourism. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hamburg, Germany
- Total investments: 19
- Last investment: May 2025
- Lead investor: 11%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/truventuro-gmbh/
- Website: http://www.truventuro.com/

TruVenturo is an entrepreneurial investor and company builder in Europe and the United States

## Contacts

5 contacts available for TruVenturo. Shizune tracks 2 team members at TruVenturo. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/truventuro-gmbh?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.1M–$24M |
| Series A | $2.4M–$20M |
| Venture - Series Unknown | $12M–$45M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Travel | 2 | 11% |
| Tourism | 2 | 11% |
| Software | 2 | 11% |
| E-Commerce | 2 | 11% |
| Hospitality | 2 | 11% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 26% |
| Series A | 5 | 26% |
| Venture - Series Unknown | 2 | 11% |
| Pre-Seed | 1 | 5% |
| Series B | 1 | 5% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 9 | 47% |
| United States | 2 | 11% |
| Spain | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Felix Schneider | Managing Director & Partner | 0 | https://shizune.co/investors/profile/felix-schneider-dda7 |
| Nils Regge | Founder & Chief Executive Officer | 4 | https://shizune.co/investors/profile/nils-regge |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tomorrow Bio | Tomorrow Bio is a Biotech firm that specializes in human cryopreservation. They use cutting-edge technology to keep you alive in the future. | $5.6M | Seed | May 22, 2025 |  |
| Rune Labs | Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developersthe performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials.Rune Labs was founded in 2018 and is headquartered in San Francisco, California. | $12M | Venture - Series Unknown | Jan 11, 2024 |  |
| get.me | get.me connects social media accounts or links to sites. They create a free link in their bio page that earns money and turns followers into paying subscribers, so they earn money from social media with every subscriber. | $769.7K | Pre-Seed | Aug 01, 2022 |  |
| MYNE Homes | MYNE Homes is a digital co-ownership platform for vacation properties. MYNE Homes was founded in 2021 and was headquartered in Berlin, Germany. | $23.9M | Seed | Jul 07, 2022 |  |
| Numa | NUMA Group is Germany's leading technology provider in the short term rental sector and driver of the new asset class Commercial Living. NUMA combined the comfort of a home with the standards of a hotel. NUMA develops new technology solutions for the real estate industry, focusing on hotels and apartment rentals. NUMA automates operationalprocesses by up to 80 percent, enabling hotel operators to save up to 60 percent through restructuring. In addition, NUMA can drive up to 40 percent in additional topline revenue. In 2020, NUMA achieved 90 percent booking occupancy even during Corona-related lockdown. | $45.1M | Venture - Series Unknown | Feb 07, 2022 |  |
| CereGate | CereGate is a Brain-Machine Interface company establishing new ways of communication. |  | Series A | Jan 12, 2022 |  |
| CereGate | CereGate is a Brain-Machine Interface company establishing new ways of communication. |  | Convertible Note | Jan 12, 2022 |  |
| INBRAIN Neuroelectronics | INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $19.8M | Series A | Mar 26, 2021 |  |
| Rune Labs | Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developersthe performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials.Rune Labs was founded in 2018 and is headquartered in San Francisco, California. | $5M | Seed | Oct 26, 2020 |  |
| CereGate | CereGate is a Brain-Machine Interface company establishing new ways of communication. |  | Series A | Sep 03, 2020 |  |

10 of 19 investments shown.

## Co-investors
- [DN Capital](https://shizune.co/investors/profile/dn-capital) — VC Fund, 4 deals together
- [Heal Capital](https://shizune.co/investors/profile/heal-capital) — VC Fund, 4 deals together
- [Cherry Ventures](https://shizune.co/investors/profile/cherry-ventures) — VC Fund, 3 deals together
- [Hasso Plattner Ventures](https://shizune.co/investors/profile/hasso-plattner-ventures) — VC Fund, 3 deals together
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 3 deals together
- [468 Capital](https://shizune.co/investors/profile/468-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Germany](https://shizune.co/investors/medical-device-investors-germany)
- [Medical Device VC Funds in Germany](https://shizune.co/investors/medical-device-vc-funds-germany)
- [Hospitality Investors in Germany](https://shizune.co/investors/hospitality-investors-germany)
- [Hospitality VC Funds in Germany](https://shizune.co/investors/hospitality-vc-funds-germany)
- [Social Media Investors in Germany](https://shizune.co/investors/social-media-investors-germany)
- [Social Media VC Funds in Germany](https://shizune.co/investors/social-media-vc-funds-germany)

## FAQ

### What does TruVenturo invest in?

TruVenturo invests primarily in Travel, Tourism and Software startups, most often at Seed and Series A stage. Most of the 19 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is TruVenturo's check size?

TruVenturo typically joins rounds of $1.1M–$24M at Seed, $2.4M–$20M at Series A and $12M–$45M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TruVenturo participates in.

### How do I contact TruVenturo?

Public channels for TruVenturo include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at TruVenturo?

The team at TruVenturo includes Felix Schneider (Managing Director & Partner) and Nils Regge (Founder & Chief Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co